Business Context and Reporting Period
Company: Bruker BioSciences Corporation
Filing Type: Form 8-K (Current Report)
Date of Report: August 3, 2004
Reporting Period: Three and six months ended June 30, 2004
This filing serves as a notification that the company held a conference call on August 3, 2004, to discuss its operational results for the specified periods. The detailed financial data is contained within the conference call transcript attached as Exhibit 99.1.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are referenced as being discussed in the attached conference call transcript (Exhibit 99.1), which is incorporated by reference but not included in the provided text.
Material Changes
The filing text does not explicitly detail material changes versus prior periods. It only indicates that such results were the subject of the August 3, 2004, conference call.
Guidance, Outlook, and Risks
Management Commentary: The company provided commentary on its results of operations during the referenced conference call.
Legal Disclaimer: The information in this Form 8-K and Exhibit 99.1 is furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934. It is not subject to the liabilities of that section and is not incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Review Exhibit 99.1 (Conference Call Transcript) for specific revenue, profit, and cash flow figures.
- Verify the company's guidance and outlook statements made during the August 3, 2004, call.
- Confirm the legal status of the information, noting it is not deemed "filed" under Section 18 of the Exchange Act.
- Check subsequent filings for any updates or corrections to the results discussed in this report.